The concluding session of the afternoon’s “Advancing Analytical Sciences” program reached its environmental sustainability crescendo as Dr. Umamaheshwar Puppala, Director and Head of Analytical (Med Chem) at Sai Life Sciences, delivered a compelling exposition on green analytical chemistry that challenged conventional pharmaceutical analysis paradigms. His presentation, “Advancements in Green Analytical Chemistry for Sustainable Methods in Drug Discovery and Development,” transcended traditional environmental consciousness to reveal sophisticated analytical strategies that simultaneously enhance sustainability, efficiency, and analytical performance.
Green Chemistry Foundation
Dr. Puppala’s systematic exposition of the twelve principles of green chemistry provided a comprehensive framework for understanding how environmental considerations can drive analytical innovation rather than constrain it. His emphasis on waste reduction, energy minimization, safer solvent utilization, and operator safety demonstrated how green analytical chemistry extends beyond environmental stewardship to encompass operational excellence and analytical sophistication.
The presentation’s integration of direct analytical techniques, miniaturization strategies, in situ measurements, and renewable reagent utilization revealed sophisticated approaches to laboratory optimization that achieve environmental objectives while enhancing analytical capabilities. Dr. Puppala’s discussion positioned green analytical chemistry not as a compromise between environmental responsibility and analytical performance, but as a strategic pathway toward superior analytical outcomes.
Ultra-Performance Liquid Chromatography
Dr. Puppala’s detailed analysis of Ultra-Performance Liquid Chromatography (UPLC) capabilities revealed sophisticated technological advancement that simultaneously addresses environmental concerns and analytical efficiency requirements. His presentation of comparative data demonstrating 4-5 fold improvements in analysis speed while reducing solvent consumption by 60-80% positioned UPLC as exemplary green analytical technology.
The speaker’s extensive experience with UPLC implementation since 2006, including collaborative development with instrument manufacturers to address initial technical challenges, provided authoritative perspective on the technology’s evolution and optimization. His discussion of the van Deemter equation’s implications for UPLC performance demonstrated sophisticated understanding of the fundamental chromatographic principles underlying green analytical advantages.
Dr. Puppala’s presentation of real-world case studies from Sai Life Sciences’ operations, including the analysis of 3,000 samples daily using UPLC methodologies, provided compelling evidence of green analytical chemistry’s practical viability at industrial scale. His development of generic 1.5-2.5 minute analytical methods capable of processing 200 samples per instrument per day demonstrated the operational efficiency achievable through green analytical approaches.
SFC: Revolutionary Green Separation Science
The presentation’s comprehensive exploration of Supercritical Fluid Chromatography (SFC) revealed perhaps the most sophisticated example of green analytical chemistry innovation. Dr. Puppala’s detailed exposition of supercritical CO₂ properties—including high diffusivity, low viscosity, and enhanced solubility characteristics—demonstrated how fundamental chemical physics principles enable revolutionary analytical capabilities.
His systematic comparison of SFC with traditional normal-phase chromatography revealed dramatic advantages including 5-10 fold improvements in analysis speed, 20-40% reduction in solvent consumption, and elimination of toxic hexane-based mobile phases. The speaker’s discussion of SFC’s ability to separate complex isomeric mixtures that challenge traditional chromatographic approaches positioned the technology as essential for contemporary pharmaceutical analysis.
Dr. Puppala’s presentation of scale-up capabilities from analytical (SFC-50) through preparative (SFC-750) applications demonstrated comprehensive green analytical solutions spanning discovery through development phases. His discussion of large-scale purification capabilities—processing 500-3000 grams per loading—revealed industrial applications that substantially reduce environmental impact while enhancing purification efficiency.
Green Chemistry in Unknown Territory
The presentation’s emphasis on drug discovery applications provided unique perspective on green analytical chemistry implementation in environments characterized by complete analytical unknowns. Dr. Puppala’s systematic description of discovery workflows—identification, isolation, characterization, method development, and validation—demonstrated how green analytical technologies address the unique challenges of analyzing compounds without literature precedent or reference standards.
His discussion of Sai Life Sciences’ daily analytical workload—3,000 LC-MS analyses and 150 purifications of unknown compounds—provided compelling context for understanding the operational requirements driving green analytical innovation. The speaker’s emphasis on high-throughput, high-speed analytical capabilities demonstrated how environmental objectives align with discovery efficiency requirements.
Case Study Analysis: Real-World Green Analytical Implementation
Dr. Puppala’s presentation of multiple detailed case studies provided authoritative evidence of green analytical chemistry’s practical advantages across diverse pharmaceutical applications. His analysis of dextromethorphan hydrobromide UPLC method development demonstrated 6-8 fold improvements in analysis speed while achieving superior peak shape and resolution compared to traditional HPLC approaches.
The speaker’s discussion of chiral separation challenges, including the analysis of compounds with multiple stereoisomers, revealed SFC’s unique capabilities for addressing analytical problems that challenge traditional chromatographic approaches. His presentation of validation data demonstrating successful SFC method development for compounds requiring 45 traditional method screening attempts provided compelling evidence of green analytical superiority.
Dr. Puppala’s analysis of PROTAC (Proteolysis Targeting Chimera) compound purification demonstrated green analytical chemistry’s applicability to cutting-edge pharmaceutical research areas. His discussion of boronic ester stability in SFC versus traditional chromatographic systems revealed specific chemical advantages of supercritical fluid-based separations.
Operational Efficiency Integration
The presentation’s exploration of stack-mode injection strategies demonstrated sophisticated operational approaches that maximize instrument utilization while maintaining green analytical principles. Dr. Puppala’s discussion of continuous sample loading based on separation timing rather than complete chromatographic cycles revealed innovative approaches to analytical throughput optimization.
His systematic analysis of energy consumption reduction—demonstrating three-fold decreases in power requirements alongside analytical speed improvements—provided compelling economic arguments for green analytical technology adoption. The integration of environmental sustainability with operational efficiency challenged traditional assumptions about the cost implications of green analytical approaches.
Scalability Challenges and Solutions
Dr. Puppala’s honest assessment of green analytical chemistry implementation challenges provided balanced perspective on technology adoption barriers. His discussion of initial capital investment requirements, CO₂ tank infrastructure needs, and sensitivity limitations for certain analytical applications demonstrated sophisticated understanding of practical implementation considerations.
The speaker’s analysis of return-on-investment challenges facing Indian pharmaceutical companies revealed the economic realities influencing green analytical technology adoption. His discussion of international client expectations for green analytical capabilities, particularly from UK and US pharmaceutical companies, demonstrated the competitive implications of sustainable analytical practices.
Green Analytical Chemistry as Competitive Advantage
Dr. Puppala’s concluding discussion positioned green analytical chemistry adoption as strategic imperative rather than optional enhancement for pharmaceutical companies seeking international competitiveness. His emphasis on environmental factor importance alongside human safety considerations demonstrated sophisticated understanding of the multiple drivers supporting green analytical innovation.
The presentation’s integration of analytical performance enhancement with environmental responsibility challenged conventional assumptions about sustainability compromises. Dr. Puppala’s assertion that green analytical methods can enhance rather than constrain analytical sensitivity and regulatory compliance provided optimistic perspective on sustainable pharmaceutical development.
Industry Context
Dr. Puppala’s presentation drew credibility from Sai Life Sciences’ extensive implementation of green analytical technologies across discovery and development operations. His discussion of client requirements for green analytical capabilities, particularly from international pharmaceutical companies, demonstrated market-driven demand for sustainable analytical practices.
The speaker’s 25-year experience in analytical chemistry, including early adoption of UPLC and SFC technologies, provided authoritative perspective on green analytical evolution and optimization. His involvement in instrument development collaborations and method optimization efforts demonstrated deep technical expertise underlying the green analytical recommendations presented.
Eco & Economic Impact Assessment
The presentation’s systematic analysis of green analytical chemistry benefits revealed substantial environmental and economic advantages achievable through technology adoption. Dr. Puppala’s documentation of dramatic reductions in toxic solvent consumption, energy utilization, and waste generation demonstrated quantifiable environmental improvements.
His discussion of analytical speed improvements—from traditional hour-long separations to 2-3 minute analyses—revealed productivity gains that substantially offset green technology implementation costs. The integration of environmental sustainability with operational efficiency provided compelling business case for green analytical adoption.
Dr. Puppala’s discussion of international pharmaceutical company expectations for green analytical capabilities revealed the competitive implications of sustainable analytical practices. His analysis of European and US client requirements for environmentally responsible analytical approaches demonstrated the global nature of green analytical chemistry adoption.
The presentation suggested that pharmaceutical companies lacking green analytical capabilities may face increasing competitive disadvantages in international markets where environmental stewardship influences client relationships and regulatory compliance expectations.
Green Analytical Chemistry as Pharmaceutical Evolution
Dr. Umanaheshwar Puppala’s presentation at Analytica Lab India 2025 positioned green analytical chemistry not as environmental accommodation but as analytical evolution that simultaneously addresses sustainability imperatives and performance enhancement objectives. His comprehensive exposition revealed sophisticated technological solutions that challenge traditional assumptions about environmental responsibility compromising analytical capabilities.
The sophisticated methodological approaches, operational efficiency improvements, and environmental benefits presented suggest that green analytical chemistry represents a fundamental transformation in pharmaceutical analytical science. Organizations that successfully implement these technologies will likely achieve competitive advantages in operational efficiency, environmental stewardship, and international market access.
Dr. Puppala’s vision of universal green analytical chemistry adoption in Indian pharmaceutical industry reflects the recognition that environmental responsibility and analytical excellence represent complementary rather than competing objectives. His presentation suggested that the future of pharmaceutical analytical science lies in technologies that enhance both environmental sustainability and analytical performance, creating value for pharmaceutical companies, regulatory agencies, and global environmental stewardship.
- Naresh Nunna
